ZNAF-1
|
- $100 - $846
- Product name: ZNAF-1
- CAS: 321859-09-0
- MF: C34H28N4O5
- MW: 572.61
- EINECS:
- MDL Number:MFCD28385815
- Synonyms:ZnAF-1 5-Iso;5-Iso-ZnAF-1;6-[2-[bis(pyridin-2-ylmethyl)amino]ethylamino]-3',6'-dihydroxyspiro[2-benzofuran-3,9'-xanthene]-1-one;5-N-[N',N'-bis(2-pyridinylmethyl)-2-aminoehtyl]amino-3',6'-dihydroxyspiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one;Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 5-[[2-[bis(2-pyridinylmethyl)amino]ethyl]amino]-3',6'-dihydroxy-;5-N-[N',N'-bis(2-pyridinylmethyl)-2-aminoehtyl]amino-3',6'-dihydroxyspiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one
3 prices
Selected condition：
Brand
- Adipogen Life Sciences
- American Custom Chemicals Corporation
- TRC
Package
- 1mg
- 5MG
- 125mg
- ManufacturerAdipogen Life Sciences
- Product numberCDX-Z0005-M125
- Product descriptionZnAF-1 ≥95%(HPCE)
- Packaging125mg
- Price$846
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberFRL0000108
- Product description5-[2-[BIS(2-PYRIDYLMETHYL)AMINO]ETHYLAMINO]FLUORESCEIN 95.00%
- Packaging5MG
- Price$500.17
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberZ701533
- Product descriptionZnAF-1
- Packaging1mg
- Price$100
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Adipogen Life Sciences | CDX-Z0005-M125 | ZnAF-1 ≥95%(HPCE) | 125mg | $846 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | FRL0000108 | 5-[2-[BIS(2-PYRIDYLMETHYL)AMINO]ETHYLAMINO]FLUORESCEIN 95.00% | 5MG | $500.17 | 2021-12-16 | Buy |
| TRC | Z701533 | ZnAF-1 | 1mg | $100 | 2021-12-16 | Buy |
Properties
Boiling point :823.6±65.0 °C(Predicted)
Density :1.47±0.1 g/cm3(Predicted)
pka :9.34±0.20(Predicted)
form :Solid
color :Brown to black
Density :1.47±0.1 g/cm3(Predicted)
pka :9.34±0.20(Predicted)
form :Solid
color :Brown to black
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|